|
|
|
LifeScienceHistory.com - Check us out on Instagram
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Palatin Technologies, Inc.
| | | Phone: | (609) 495-2200 | Fax: | (609) 495-2201 | Year Established: | 1996 | Employees: | 20 | Ticker: | PTN | Exchange: | NYSE | Main Contact: | Libby Keating, VP, Commercial Development | | Other Contacts: | Carl Spana, Ph.D., President & CEO Stephen T. Wills, C.P.A., M.S.T., CFO & COO Johna Lucas, M.A., M.D., F.A.C.O.G., CMO
| | Company Description | Palatin is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems.
Palatin has a diverse pipeline of active development programs targeting melanocortin and natriuretic receptors, including acute hospital care products in the cardiovascular field for treatment of congestive heart failure, hard-to-control hypertension and for cardiac surgery organ protection, and products for sexual dysfunction, obesity and metabolic syndrome. | |
|
|
|
|
|